Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)

Market Cap	10.38M
Revenue (ttm)	6.03M
Net Income (ttm)	352.82K
Shares Out	8.58M
EPS (ttm)	0.04
PE Ratio	29.42
Forward PE	11.00
Dividend	0.06 (4.88%)
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	4,250
Open	1.230
Previous Close	1.230
Day's Range	1.230 - 1.230
52-Week Range	0.880 - 1.700
Beta	1.34
RSI	42.08
Earnings Date	Sep 26, 2025

About Ligand Pharmaceuticals

Laboratorio Farmaceutico Erfo S.p.A. engages in the formulation and production of food supplements in Italy. It produces various types of pharmaceutical forms, such as bottles, single-dose vials and bottles, capsules, tablets, and sachets under the Diètnatural and Gianopharma brands, as well as private label brands. The company offers custom formula creation, regulatory advice, graphics, and packaging services. The company was founded in 2013 and is based in Villafranca Tirrena, Italy.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2013
• Employees: 41
• Stock Exchange: Borsa Italiana
• Ticker Symbol: ERFO

Financial Performance

In 2024, BIT:ERFO's revenue was 6.03 million, an increase of 1.69% compared to the previous year's 5.93 million. Earnings were 352,819, a decrease of -40.23%.